Banking

6 reasons why Rocket Cos. considers itself a fintech company

Since Rocket Cos. (NYSE: RKT) was made public earlier this month, there has been a debate over whether the country’s largest mortgage lender is really a fintech or rather a traditional consumer finance company. Shares in Rocket’s initial public offering were priced at $ 18 per share, below the company’s …

Read More »

Huntington Bancshares to Acquire TCF Financial and Create Top 10 U.S. Banks

Assets of $ 120 billion Huntington Bancshares (NASDAQ: HBAN), based in Columbus, Ohio, announced a definitive agreement to acquire the $ 48 billion asset TCF Financial (NASDAQ: TCF), based in Detroit, Michigan. The transaction will create one of the top 10 banks in the United States and give Huntington a …

Read More »

My best COVID stock for 2021

If you invested $ 10,000 in shares of the coronavirus vaccine maker Moderna (NASDAQ: mRNA) last year, this capital would have reached more than $ 52,000 as of January 15. The company is one of the hottest biotechs on the market after its IPO just over two years ago – …

Read More »

Can Student Loan Forbearance Help? 5 ways to find out

You’ve seen the headlines: Stop Paying Your Student Loans! But can you really? And should you? If you have student loans held by the federal government, the $ 2.2 trillion from the U.S. government the coronavirus relief package covered a period of abstention this has been extended until December 31, …

Read More »

FDA tells Intercept Pharmaceuticals no on its drug candidate NASH – for now

Millions of people with progressive liver disease will have to wait longer for treatment to become available. The FDA refused to approve an application for obeticholic acid (OCA) for patients with advanced non-alcoholic steatohepatitis (NASH). Instead, the agency told the resort owner, Intercept pharmaceuticals (NASDAQ: ICPT), to try again and …

Read More »

Here’s what you need to know about the new strains of COVID – and how today’s vaccines hold up

Everyone has been talking about the new strains of coronavirus, especially those originating in the UK and South Africa. The concern is whether the Pfizer (NYSE: PFE) and Moderna (NASDAQ: mRNA) vaccines can protect against these variants. In this Motley Fool Live video recorded on January 22, 2021, Corinne Cardina, …

Read More »

3 best biotech stocks to buy right now

Choosing the best biotech stocks can sometimes seem like a game of luck. Trying to determine which company drug candidate is most likely to work, or whether your stake will be diluted as the company tries to secure funding to continue a trial, can often feel like a guessing game. …

Read More »

2 cheap growth stocks to buy now

Most of the major U.S. stock indexes have rebounded strongly since hitting a multi-year low on March 23, 2020. Dow Jones Industrial Average has gained 26% in good health over the past two and a half weeks, while the S&P 500 increased by almost 23% over the same period. Despite …

Read More »

Can Bluebird Bio recover from another major setback?

Actions of organic blue bird (NASDAQ: BLUE) recently took a hit after the company’s lead nominee encountered an issue investors find all too familiar. The company will no longer seek approval of bb1111 as a treatment for sickle cell anemia (SCD) in the second half of 2021, as planned. Instead, …

Read More »

Why Matinas BioPharma Holdings grew almost 28% today

What happened Company shares at clinical stage Matinas BioPharma Holdings (NYSEMKT: MTNB) rose 27.9% on Monday, following the announcement of the crucial Food and Drug Administration approval. So what Matinas said Monday it received conditional approval from the FDA for the brand name of its main pipeline drug, MAT9001 / …

Read More »